Key clinical point: A large proportion of IBD patients initiating biologic therapy continue to experience persistent fatigue.
Major finding: Among the 198 patients who reported fatigue, 44 (61%) remained fatigued at week 54.
Study details: A prospective study of 326 IBD patients.
Disclosures: The researchers reported having no financial disclosures.
REPORTING FROM DDW 2019